info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map Crossmark Policy
ISSN: 2574 -1241

Impact Factor : 0.548

Menu

e-Prints

PD-1/PD-L1 Checkpoint in Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report

Case Report

Article Title: PD-1/PD-L1 Checkpoint in Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report

Author: Antonella Bianchi*, Simona Ferrari, Gabriella Gullotta, Antonella Grasso, Ombretta Annibali

Published Date: March 16, 2018

DOI: 10.26717/BJSTR.2018.03.000865

Abstract:

Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a rare form of malignancy that arises around mammary implants in patients undergoing prosthetic surgery. It has been included as a provisional entity in the revised WHO classification of lymphoid malignancy. The PD-1/PD-L1 axis is one of the major mechanisms of immune escaping exerted by several cancer types in which up-regulation of PD-L1 is observed. We report the presence of PD-1/PD-L1 checkpoint in a case of BI-ALCL of a 67 year old woman, whom previously had undergone mastectomy and reconstruction for breast carcinoma.

Featured Reprints

view all